ImmunoCellular (IMUC)
0.335
-0.00 -0.95%
NYSE MKT
Aug 18, 20:00
Delayed 2m
USD
View All Key Stats
IMUC Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -6.151 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -20.56M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 5.307M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -3.453M |
| Return on Equity (TTM) | -- |
View All IMUC News
IMUC News
-
WireHeadlineTime (ET)
-
PR Newswire08/15 17:00
-
SA Breaking News08/14 18:02
-
PR Newswire08/14 18:00
-
PR Newswire08/09 06:25
-
PR Newswire07/28 17:49
-
PR Newswire07/27 17:49
-
PR Newswire07/20 16:01
-
Yahoo07/19 08:10
-
MT Newswires07/18 16:24
-
MT Newswires07/18 15:58
View All Events
IMUC Events
| Date | Type | Description |
|---|---|---|
| 05/15/2017 | Earnings | ImmunoCellular Therapeutics Ltd First Quarter Earnings in 2017 Release |
| 05/15/2017 | Misc | ImmunoCellular Therapeutics Ltd First Quarter Earnings Conference Call in 2017 |
| 03/09/2017 17:00 EDT | Misc | ImmunoCellular Therapeutics Ltd Fourth Quarter Earnings Conference Call in 2016 |
| 03/09/2017 | Earnings | ImmunoCellular Therapeutics Ltd Fourth Quarter Earnings in 2016 Release |
| 11/21/2016 | Splits | Ratio: 1:40 |
| 11/10/2016 17:00 EST | Misc | ImmunoCellular Therapeutics Ltd Third Quarter Earnings Results in 2016 |
| 11/10/2016 | Earnings | ImmunoCellular Therapeutics Ltd Third Quarter Earnings Results in 2016 Release |
| 08/22/2016 14:00 PDT | Misc | ImmunoCellular Therapeutics Ltd Second Quarter Earnings Conference Call in 2016 |
| 08/22/2016 | Earnings | ImmunoCellular Therapeutics Ltd Second Quarter Earnings in 2016 Release |
IMUC Fundamentals
Income Statement View Statement
Cash Flow Statement View Statement
IMUC Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
IMUC One Page Reports
- One Page Report Download
IMUC Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 0.335 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.imuc.com
- Investor Relations URL: http://investors.imuc.com/index.cfm
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 15, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: ImmunoCellular Therapeutics Ltd is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.
IMUC Comparables
EditIMUC Excel Add-In Codes
- Name: =YCI("IMUC","name")
- Description: =YCI("IMUC","description")
- Sector: =YCI("IMUC","sector")
- Industry: =YCI("IMUC","industry")
- Est. Current Fiscal Year End: =YCI("IMUC","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other IMUC Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- IMUC Tweets Stocktwits
Advertisement
